JOHNSON & JOHNSON — Director's Dealing 2018

Jul 4, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Provention Bio, Inc. (PRVB)
CIK: 0001695357
Period of Report: 2018-07-03

Reporting Person: JOHNSON & JOHNSON (10% Owner)
Reporting Person: Johnson & Johnson Innovation - JJDC, Inc. (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (2400000)		Indirect

Footnotes

F1: The Series A Preferred Stock has no expiration date and will automatically convert into shares of Common Stock on a 1-1 basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering.

F2: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.